| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 79,000 | 02 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | 02 Jan 2024 | 1 | $0 | 4 | Chief Business Officer | 04 Jan 2024, 16:15 |
| GLUE | Monte Rosa Therapeutics, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Chief Business Officer | 04 Jan 2023, 15:30 |
| GLUE | Monte Rosa Therapeutics, Inc. | 01 Mar 2022 | 1 | $0 | 4 | Chief Business Officer | 02 Mar 2022, 17:49 |
| GLUE | Monte Rosa Therapeutics, Inc. | 01 Dec 2021 | 0 | $0 | 3 | Chief Business Officer | 02 Dec 2021, 17:12 |